ABSTRACT
Ubiquitination, one of the posttranslational modifications, appears to be involved in the transcriptional activity of nuclear receptors including retinoic acid receptor α (RARα). We previously reported that an E3 ubiquitin ligase, TRIM32, interacts with several important proteins including RARα and enhances transcriptional activity of RARα in mouse neuroblastoma cells and embryonal carcinoma cells. Retinoic acid (RA), which acts as a ligand to nuclear receptors including RARα, plays crucial roles in development, differentiation, cell cycles and apoptosis. In this study, we found that TRIM32 enhances RARα-mediated transcriptional activity even in the absence of RA and stabilizes RARα in the human promyelogenous leukemic cell line HL60. Moreover, we found that overexpression of TRIM32 in HL60 cells suppresses cellular proliferation and induces granulocytic differentiation even in the absence of RA. These findings suggest that TRIM32 functions as one of the coactivators for RARα-mediated transcription in acute promyelogenous leukemia (APL) cells, and thus TRIM32 may become a potentially therapeutic target for APL.
TRIM32 promotes retinoic acid receptor α-mediated differentiation in human promyelogenous leukemic cell line HL60
Riferimento:
Biochem Biophys Res Commun. 2012 Jan 6;417(1):594-600.
Autori:
Sato T, Okumura F, Iguchi A, Ariga T, Hatakeyama S.
Fonte:
Biochem Biophys Res Commun. 2012 Jan 6;417(1):594-600.
Anno:
2012
Azione:
La funzione genica del TRIM32 è uno dei coattivatori per la trascrizione mediata da RARα nelle cellule della leucemia acuta promielocitica (APL).
Target:
RARα/leucemia acuta promielocitica.
Sostanze:
